The results showed increased PFN2 levels in the serum of patients with MI, especially in patients after 8–15 days post-MI (p = 0.021) compared to their corresponding CTL, consistent with the levels of VEGFA and bFGF (Figure 1A). This evidence concerns the gene PFN2 and myocardial infarction.